The role of oxidative stress and endothelial injury in diabetic neuropathy and neuropathic pain

Neuroendocrinology Letters

Volumn 31, Issue 2, 2010, Pages 261-264

  Ozkul, Ayca ^a   Ayhan, Mediha ^a   Yenisey, Cigdem ^a   Akyol, Ali ^a   Guney, Engin ^a   Ergin, Filiz Abacigil ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Diabetes; Endothelin; Neuropathy; Oxidative stress

Indexed keywords

ANTIDIABETIC AGENT; CATALASE; ENDOTHELIN 1; GLUTATHIONE; NITRIC OXIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIABETIC NEUROPATHY; DISEASE DURATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM INJURY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MALE; NEUROPATHIC PAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; SMOKING; BLOOD; ENDOTHELIUM; METABOLISM; MIDDLE AGED; NEURALGIA; PATHOPHYSIOLOGY; QUESTIONNAIRE;

ADULT; AGED; CATALASE; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; ENDOTHELIN-1; ENDOTHELIUM; FEMALE; GLUTATHIONE; HUMANS; MALE; MIDDLE AGED; NEURALGIA; NITRIC OXIDE; OXIDATIVE STRESS; QUESTIONNAIRES;

EID: 77952404321     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Cooper ME, Johnston CI. (2000). Optimizing treatment of hypertension in patients with diabetes. JAMA. 283:3177-3179. (Pubitemid 30422022)
2. Koya D, King GL. (1998). Protein kinase C activation and the development of diabetic complications. Diabetes. 47:859-866, (Pubitemid 28255657)
3. Cameron NE, Cotter MA. (1996). Effects of a non-peptide endothelin-1 ET-A antagonist on neurovascular function in diabetic rats: interaction with the reninangiotensin system. J Pharmacol Exp Ther. 278:1262-1268.
4. Vincent AM, Russell JW, Low P, Feldman EL. (2004). Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr. Rev. 25:612-628.
5. Pacher P, Obrosova IG, Mabley JG, Szabo C. (2005). Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr. Med. Chem. 12:267-275.
6. Edwards JL, Vincent AM, Cheng HL, Feldman EL. (2008). Diabetic Neuropathy: Mechanisms to Management. Pharmacology and Therapeutics 120:1-34.
7. Aebi H. (1974). Catalase. In: Bergmeyer HU, editors. Methods of enzymatic analysis, 2nd edition, New York: Academic Press. pp 673-677.
8. Navarro-Gonzalves JA, Garcia-Benayas C, Arenas J. (1998). Semi-automated measurement of nitrate in biological fluids. Clin. Chem. 44:679-681.
9. Beutler E, Durgun O, Kelly BM. (1963). Improved method for the determination of blood glutathione. J Lab Clin Med 51:882-888.
10. Cooper ME, Gilbert RE, Epstein M. (1998). Pathophysiology of diabetic nephropathy. Metabolism 47:3-6.
11. Brownlee M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature. 414:813-820. (Pubitemid 34000785)
12. Leinninger GM, Edwards JL, Lipshaw MJ, Feldman EL. (2006). Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy. Nature clinical practice. 2:620-628.
13. Bertello P, Veglio F, Pinna G, Gurilo L, Molino P, Alban S, Chiandussi L. (1994). Plasma endothelin in NIDDM patients with and without complications. Diabetes Care. 17:574-577.
14. Guvener N, Aytemir K, Aksoyek K, Gedik O. (1997). Plasma endothelin-1 levels in noninsulin-dependent diabetes mellitus patients with macrovascular disease. Coron Artery Dis. 8: 253-258. (Pubitemid 27359171)
15. Veglio F, Bertello P, Pinna G, Mulatero P, Rossi A, Gurioli L, Panarelli M, Chiandussi L. (1993). Plasma endothelin in essential hypertension and diabetes mellitus. J Hum Hypertens. 7: 321-325.
16. Vertello P, Veglio F, Pinna G, Gurioli L, Molino P. (1993). Plasma endothelin in Type 2 diabetes mellitus patients with and without complications. Diabetes Care. 17:574-577.
17. Berti-Mattera LN, Gariepy CE, Burke RM, Hall AK. (2006). Reduced expression of endothelin B receptors and mechanical hyperalgesia in experimental chronic diabetes. Exp. Neurol. 201:399-406.
18. Kim JE, Kim AR, Chung HY, Han SY, Kim BS, Choi JS. (2003). In vitro peroxynitrite scavenging activity of diarylheptanoids from Curcuma longa. Hytother.Res. 17:481-484.
19. Kuhad A, Chopra K. (2009). Tocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy. Neuropharmacology 57:456-462.